Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pt(IV) Prodrugs with NSAIDs as Axial Ligands
Daniil Spector, Olga O. Krasnovskaya, Kirill G. Pavlov, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3817-3817
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Riding the metal wave: A review of the latest developments in metal-based anticancer agents
Sara Abdolmaleki, Alireza Aliabadi, Samad Khaksar
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215579-215579
Closed Access | Times Cited: 58
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 954-954
Open Access | Times Cited: 55
Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance
Mona Shahlaei, Shaahin Mohammadzadeh Asl, Atefe Derakhshani, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137366-137366
Closed Access | Times Cited: 25
Novel Maleimide Linkers Based on a Piperazine Motif for Strongly Increased Aqueous Solubility
Martijn Dijkstra, Hemma Schueffl, Anja Federa, et al.
ACS Omega (2025) Vol. 10, Iss. 5, pp. 5047-5063
Open Access | Times Cited: 1
Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response
Zuojie Li, Qingpeng Wang, Linming Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 17920-17935
Closed Access | Times Cited: 48
Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position
Daniil Spector, Kirill G. Pavlov, Roman Akasov, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8227-8244
Closed Access | Times Cited: 36
NSAID–Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
Zhongren Xu, Qiuyue Lu, Min Shan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 7813-7833
Closed Access | Times Cited: 22
Special Issue “Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0”
Valentina Gandin, James D. Hoeschele, Nicola Margiotta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7917-7917
Open Access | Times Cited: 21
Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug
Olga O. Krasnovskaya, Roman Akasov, Daniil Spector, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 10, pp. 12882-12894
Closed Access | Times Cited: 20
Current Status of Novel Multifunctional Targeted Pt(IV) Compounds and Their Reductive Release Properties
Ling‐Wen Xu, Xiangyu Kong, Xinzhi Li, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 746-746
Open Access | Times Cited: 6
A series of ligustrazine platinum(iv) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects
Yan Chen, Linming Li, Zhifang Liu, et al.
Dalton Transactions (2023) Vol. 52, Iss. 37, pp. 13097-13109
Closed Access | Times Cited: 13
Amlexanox-modified platinum(IV) complex triggers apoptotic and autophagic bimodal death of cancer cells
Yan Guo, S. Jin, Dongfan Song, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114691-114691
Closed Access | Times Cited: 22
In Vitro/In VivoElectrochemical Detection of Pt(II) Species
Alexander N. Vaneev, Petr V. Gorelkin, Olga O. Krasnovskaya, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 12, pp. 4901-4905
Open Access | Times Cited: 19
Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
Aleen Khoury, Jennette A. Sakoff, Jayne Gilbert, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 787-787
Open Access | Times Cited: 19
Multi-specific niflumic acid platinum(iv) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage
Linming Li, Ming Zhang, Dianlong Jia, et al.
Dalton Transactions (2022) Vol. 52, Iss. 1, pp. 147-158
Closed Access | Times Cited: 19
Discovery of PlatinumIV–Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial Agents
Wei Liu, Chuyi Yu, Miaomiao Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 8066-8085
Closed Access | Times Cited: 12
Novel platinum(IV) prodrugs with tetraacetylriboflavin axial ligand possessing enhanced light-induced toxicity
Daniil Viktorovich Spector, Roman Akasov, Dmitrii M. Mazur, et al.
Mendeleev Communications (2025) Vol. 35, Iss. 3, pp. 282-284
Closed Access
Pt(IV) Complexes as Anticancer Drugs and Their Relationship with Oxidative Stress
Vlad Iova, R.C. Tincu, Ioana Scrobotă, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 981-981
Open Access
Structural and Biological Properties of Heteroligand Copper Complexes with Diethylnicotinamide and Various Fenamates: Preparation, Structure, Spectral Properties and Hirshfeld Surface Analysis
Milan Piroš, Martin Schoeller, Katarína Koňariková, et al.
Inorganics (2023) Vol. 11, Iss. 3, pp. 108-108
Open Access | Times Cited: 10
Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial–Mesenchymal Transition Suppression, and Immune Activation Properties
Ming Zhang, Yan Chen, Shuaiqi Feng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16416-16434
Closed Access | Times Cited: 3
Organic Chemistry in Russian Universities. Achievements of Recent Years
Ivan I. Stoikov, И. С. Антипин, В. А. Бурилов, et al.
Russian Journal of Organic Chemistry (2024) Vol. 60, Iss. 8, pp. 1361-1584
Closed Access | Times Cited: 3
Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo
Linming Li, Yan Chen, Qingpeng Wang, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 5513-5529
Open Access | Times Cited: 21
Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs
Daniil Spector, Kirill G. Pavlov, Елена К. Белоглазкина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14511-14511
Open Access | Times Cited: 14
Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines
Marie‐Christin Barth, Norman Häfner, Ingo B. Runnebaum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5718-5718
Open Access | Times Cited: 7
Multi-action platinum(IV) prodrugs conjugated with COX-inhibiting NSAIDs
Xiao Liu, Dominik Wenisch, Philipp Dahlke, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115515-115515
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top